Skip to main content

Advertisement

Figure 2 | Journal of Experimental & Clinical Cancer Research

Figure 2

From: Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients

Figure 2

Kaplan-Meier survival curves for Nestin (A) and CD133 (B) expression in gliomas tissues. 'a', categorized by negative Nestin or CD133 expression; 'b', categorized by weak~moderate positive Nestin or CD133 expression; 'c', categorized by strong positive Nestin or CD133 expression. Survival was significantly poor for patients with strong positive Nestin or CD133 expression than those with negative expression (both p < 0.01).

Back to article page